1. Home
  2. NVR vs TEVA Comparison

NVR vs TEVA Comparison

Compare NVR & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVR
  • TEVA
  • Stock Information
  • Founded
  • NVR 1980
  • TEVA 1901
  • Country
  • NVR United States
  • TEVA Israel
  • Employees
  • NVR N/A
  • TEVA N/A
  • Industry
  • NVR Homebuilding
  • TEVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVR Consumer Discretionary
  • TEVA Health Care
  • Exchange
  • NVR Nasdaq
  • TEVA Nasdaq
  • Market Cap
  • NVR 22.4B
  • TEVA 21.2B
  • IPO Year
  • NVR N/A
  • TEVA N/A
  • Fundamental
  • Price
  • NVR $8,510.43
  • TEVA $18.95
  • Analyst Decision
  • NVR Buy
  • TEVA Strong Buy
  • Analyst Count
  • NVR 4
  • TEVA 7
  • Target Price
  • NVR $8,783.33
  • TEVA $24.71
  • AVG Volume (30 Days)
  • NVR 16.5K
  • TEVA 10.1M
  • Earning Date
  • NVR 10-21-2025
  • TEVA 11-05-2025
  • Dividend Yield
  • NVR N/A
  • TEVA N/A
  • EPS Growth
  • NVR N/A
  • TEVA N/A
  • EPS
  • NVR 474.94
  • TEVA N/A
  • Revenue
  • NVR $10,717,672,000.00
  • TEVA $16,628,000,000.00
  • Revenue This Year
  • NVR N/A
  • TEVA $4.07
  • Revenue Next Year
  • NVR N/A
  • TEVA $0.81
  • P/E Ratio
  • NVR $17.90
  • TEVA N/A
  • Revenue Growth
  • NVR 5.86
  • TEVA 2.08
  • 52 Week Low
  • NVR $6,562.85
  • TEVA $12.47
  • 52 Week High
  • NVR $9,964.77
  • TEVA $22.80
  • Technical
  • Relative Strength Index (RSI)
  • NVR 67.65
  • TEVA 66.51
  • Support Level
  • NVR $8,027.53
  • TEVA $17.89
  • Resistance Level
  • NVR $8,303.30
  • TEVA $18.96
  • Average True Range (ATR)
  • NVR 172.87
  • TEVA 0.52
  • MACD
  • NVR 18.08
  • TEVA 0.06
  • Stochastic Oscillator
  • NVR 86.20
  • TEVA 91.24

About NVR NVR Inc.

NVR Inc is a United States-based homebuilding company. It builds single-family detached homes, townhomes, and condominium buildings under three brands, Ryan Homes, NVHomes, and Heartland Homes. The company through its subsidiary also operates a mortgage banking and title services business. The homebuilding segment includes four geographic areas of the Mid-Atlantic, North East, Mid-East, and South East.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: